178
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis and pregnancy outcomes of fetuses with polyhydramnios

, , , , , , , , , & show all
Article: 2344089 | Received 29 Jan 2024, Accepted 12 Apr 2024, Published online: 06 May 2024

References

  • Magann EF, Chauhan SP, Doherty DA, et al. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007;62(12):1–9. doi: 10.1097/01.ogx.0000290349.58707.e0.
  • Dashe JS, Pressman EK, Hibbard JU, et al. SMFM consult series #46: evaluation and management of polyhydramnios. Am J Obstet Gynecol. 2018;219(4):B2–B8. doi: 10.1016/j.ajog.2018.07.016.
  • Shimada S, Yamada H, Hoshi N, et al. Specific ultrasound findings associated with fetal chromosome abnormalities. Congenit Anom. 2009;49(2):61–65. doi: 10.1111/j.1741-4520.2009.00224.x.
  • Enzensberger C, Pulvermacher C, Degenhardt J, et al. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling. Ultraschall Med. 2012;33(7):E75–E79. doi: 10.1055/s-0031-1299388.
  • Sagi-Dain L, Sagi S. Chromosomal aberrations in idiopathic polyhydramnios: a systematic review and meta-analysis. Eur J Med Genet. 2015;58(8):409–415. doi: 10.1016/j.ejmg.2015.06.010.
  • Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril. 2018;109(2):201–212. doi: 10.1016/j.fertnstert.2018.01.005.
  • Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184. doi: 10.1056/NEJMoa1203382.
  • Sagi-Dain L, Singer A, Falik-Zaccai T, et al. The effect of polyhydramnios degree on chromosomal microarray results: a retrospective cohort analysis of 742 singleton pregnancies. Arch Gynecol Obstet. 2021;304(3):649–656. doi: 10.1007/s00404-021-05995-y.
  • Shi P, Hou Y, Chen D, et al. Estimate of genetic variants using CNV-seq for fetuses with oligohydramnios or polyhydramnios. Mol Genet Genomic Med. 2023;11(1):e2089.
  • Wu X, Li Y, Lin N, et al. Evaluation of genetic variants using chromosomal microarray analysis for fetuses with polyhydramnios. BMC Med Genomics. 2022;15(1):73. doi: 10.1186/s12920-022-01224-w.
  • Pagan M, Magann EF, Rabie N, et al. Idiopathic polyhydramnios and pregnancy outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023;61(3):302–309. doi: 10.1002/uog.24973.
  • Luo QQ, Zou L, Gao H, et al. Idiopathic polyhydramnios at term and pregnancy outcomes: a multicenter observational study. J Matern Fetal Neonatal Med. 2017;30(14):1755–1759. doi: 10.1080/14767058.2016.1224835.
  • Wax JR, Cartin A, Craig WY, et al. Transient idiopathic polyhydramnios: maternal and perinatal outcomes: maternal and perinatal outcomes. J Ultrasound Med. 2022;41(11):2859–2866. doi: 10.1002/jum.15974.
  • Dashe JS, McIntire DD, Ramus RM, et al. Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol. 2002;100(1):134–139. doi: 10.1097/00006250-200207000-00021.
  • Kouamé N, N’goan-Domoua AM, Nikiéma Z, et al. Polyhydramnios: a warning sign in the prenatal ultrasound diagnosis of foetal malformation? Diagn Interv Imaging. 2013;94(4):433–437. doi: 10.1016/j.diii.2013.01.002.
  • Zhang Z, Hu T, Wang J, et al. Prenatal diagnostic value of chromosomal microarray in fetuses with nuchal translucency greater than 2.5 mm. Biomed Res Int. 2019;2019:6504159. doi: 10.1155/2019/6504159.
  • Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the clinical genome resource (ClinGen). Genet Med. 2020;22(2):245–257. doi: 10.1038/s41436-019-0686-8.
  • Tartaglia NR, Howell S, Sutherland A, et al. A review of trisomy X (47,XXX). Orphanet J Rare Dis. 2010;5(1):8. doi: 10.1186/1750-1172-5-8.
  • Davis SM, Bloy L, Roberts TPL, et al. Testicular function in boys with 47,XYY and relationship to phenotype. Am J Med Genet C Semin Med Genet. 2020;184(2):371–385. doi: 10.1002/ajmg.c.31790.
  • Zhang Z, Hu T, Wang J, et al. Pregnancy outcomes of fetuses with congenital heart disease after a prenatal diagnosis with chromosome microarray. Prenat Diagn. 2022;42(1):79–86. doi: 10.1002/pd.6078.
  • Hu T, Tian T, Zhang Z, et al. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study. Am J Obstet Gynecol. 2021;224(5):516 e511–516 e516.
  • Hu T, Zhang Z, Wang J, et al. Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis in fetuses with ultrasound anomalies in the urinary system. Prenat Diagn. 2019;39(12):1096–1106. doi: 10.1002/pd.5550.
  • Jing XY, Huang LY, Zhen L, et al. Prenatal diagnosis of 17q12 deletion syndrome: a retrospective case series. J Obstet Gynaecol. 2019;39(3):323–327. doi: 10.1080/01443615.2018.1519693.
  • Zhang Z, Pan L, Chen K, et al. Prenatal ultrasound features and genetic analysis for 17q12 microdeletion syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(12):1370–1374. doi: 10.11817/j.issn.1672-7347.2021.210412.
  • Khan S, Donnelly J. Outcome of pregnancy in women diagnosed with idiopathic polyhydramnios. Aust N Z J Obstet Gynaecol. 2017;57(1):57–62. doi: 10.1111/ajo.12578.
  • Zeino S, Carbillon L, Pharisien I, et al. Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios. J Gynecol Obstet Hum Reprod. 2017;46(4):349–354. doi: 10.1016/j.jogoh.2017.02.014.
  • Polnaszek B, Liang B, Zhang F, et al. Idiopathic polyhydramnios and neonatal morbidity at term. Am J Perinatol. 2021;40(16):1827–1833. doi: 10.1055/s-0041-1739435.
  • Manickam K, McClain MR, Demmer LA, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(11):2029–2037. doi: 10.1038/s41436-021-01242-6.